ARGX:NASDAQ
argenx SE - ADR
919,21 US$
arrow_downward
-1,79%(-16,79) 1D
2 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
926,86 US$
High
928,96 US$
Low
912,96 US$
Mkt. cap
58,57 მლრდ.
Avg. vol.
255,29 ათ.
Volume
10,00
P/E ratio
34,92
52-wk high
1 072,75 US$
52-wk low
661,85 US$
EPS
26,32 US$
Beta
0,45
Shares outstanding
62,56 მლნ.
No. of employees
2 ათ.
Open
926,86 US$
High
928,96 US$
Low
912,96 US$
Mkt. cap
58,57 მლრდ.
Avg. vol.
255,29 ათ.
Volume
10,00
P/E ratio
34,92
52-wk high
1 072,75 US$
52-wk low
661,85 US$
EPS
26,32 US$
Beta
0,45
Shares outstanding
62,56 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Yahoo Finance
·
1 საათის წინ
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
AD HOC NEWS
·
1 დღის წინ
argenx stock falls 1.79 percent as Goldman raises its target
AD HOC NEWS
·
2 დღის წინ
Argenx stock after-hours at EUR 815.70: minus 2.59 percent versus prior close
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR